Skip to content
initiative Octalfa
Engagés pour l'innovation et la santé
initiative Octalfa
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • French
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • French

20 January 2021

You are here:
  1. Home
  2. 2021
  3. January
  4. 20

Amolyt Pharma Receives Orphan Drug Designation for AZP-3601 for the Potential Treatment of Hypoparathyroidism

UncategorizedBy Charlotte Maddalena20 January 2021
Go to Top